Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S Ibuprofen. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1314336A details a novel two-component resolution method for high-purity (S)-(+)-ibuprofen, offering significant cost and time advantages for pharmaceutical manufacturing supply chains.
Patent CN101104861B reveals a novel Yarrowia lipolytica lipase method for S-ibuprofen. Discover cost-effective, high-selectivity biocatalysis for pharmaceutical manufacturing.
Patent CN87100031A reveals microbial hydrolysis for high-purity S-Naproxen. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN102850204B details advanced chiral resolution for NSAIDs. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.